News from Edison Investment Research A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

05 Jun, 2017, 07:26 ET Edison Issues Outlook on Genkyotex (GKTX)

Genkyotex is a Euronext-listed company formed by the merger of Genticel and Genkyotex focused on NOX science and its application in fibrosis and...


25 May, 2017, 07:58 ET Edison Issues ADR Outlook on Novogen (NVGN)

Novogen's recent market updates presented mixed news for investors. Recruitment in the Cantrixil Phase I is underway and preparations for the...


12 May, 2017, 06:14 ET Edison Issues Update on SNP Schneider-Neureither & Partner (SHF)

SNP is acquiring BCC, one of the largest SAP partners in Central and Eastern Europe, for an undisclosed price. The deal broadens the group's...


12 May, 2017, 04:01 ET Edison Issues Outlook on Hybrigenics (ALHYG)

Hybrigenics' main focus is the development of inecalcitol as a niche treatment for leukaemia. In February it presented encouraging initial...


11 May, 2017, 12:00 ET Edison Issues ADR Outlook on Hutchison China MediTech (HCM)

Despite a strong run over the last 12 months, our increased valuation of $2.7bn suggests the market overlooks HCM's full R&D potential....


11 May, 2017, 08:31 ET Edison Issues Outlook on Epwin Group (EPWN)

FY16 earnings showed a good step forward without much help from markets. Acquisitions played a part in this as Epwin further built out its...


11 May, 2017, 06:03 ET Edison Issues Initiation on Marshall Motor Holdings (MMH)

As Marshall Motor (MMH) celebrates the second anniversary of its flotation on AIM, it can reflect positively on the continuation of its strong...


11 May, 2017, 06:02 ET Edison Issues Outlook on Hutchison China MediTech (HCM)

Despite a strong run over the last 12 months, our increased valuation of $2.7bn suggests the market overlooks HCM's full R&D potential....


11 May, 2017, 05:55 ET Edison Issues Initiation on Nanoco Group (NANO)

We believe that factors are finally aligning to support adoption of Nanoco's quantum dots in the 250m+ unit per year TV and computer display...


02 May, 2017, 12:12 ET Edison Issues Update on SNP Schneider-Neureither & Partner (SHF)

Growth slowed in Q1, as the group focused its attention on delivering its strong backlog. Nevertheless, business remains healthy and management...


02 May, 2017, 07:31 ET Edison Issues Outlook on Oryzon Genomics (ORY)

Oryzon has been making steady progress with its epigenetics R&D pipeline. Following positive Phase I/IIa trial results in December 2016,...


28 Apr, 2017, 09:13 ET Edison Issues ADR Outlook on National Grid (NGG)

National Grid's high visibility revenues, underwritten by regulatory returns across the UK and US, offer equity holders an attractive combination...


18 Apr, 2017, 05:11 ET Edison Issues Initiation on Arix Bioscience (ARIX)

We are initiating coverage on Arix Bioscience following its February 2017 IPO that raised £113m. Arix is a new transatlantic life sciences...


06 Apr, 2017, 07:40 ET Edison Issues ADR Update on Liquefied Natural Gas Ltd (LNGLY US)

Liquefied Natural Gas Ltd (LNGL) has made progress in the last six months towards Final Investment Decision (FID). Signing binding tolling...


05 Apr, 2017, 11:17 ET Edison Issues Outlook on GW Pharmaceuticals (GWPH)

Positive data from the two Phase III trials in Lennox-Gastaut syndrome (LGS) patients, coupled with the previously announced positive Dravet...


05 Apr, 2017, 05:16 ET Edison Issues Update on Quantum Genomics (ALQGC)

Quantum Genomics reported its yearly results, which highlighted the significant progress the company has made towards the commercialisation of...


31 Mar, 2017, 03:50 ET Edison Issues Update on Immunovia (IMMUNOV)

Immunovia has announced final top-line data of the IMMray platform from a retrospective study in autoimmune diseases. The study showed that the...


23 Mar, 2017, 10:14 ET Edison Issues ADR Update on Prima BioMed (PBMD)

Prima BioMed has presented encouraging early signs of efficacy from the TACTI-mel trial of IMP321 in combination with Keytruda, with one of the...


23 Mar, 2017, 05:46 ET Edison Issues Outlook on ReNeuron Group (RENE)

ReNeuron reported in December 2016 positive Phase II trial data for its CTX cells in chronic stroke patients, despite not meeting the three-month...


15 Mar, 2017, 09:35 ET Edison Issues Initiation on Blancco Technology Group (BLTG)

As the leading provider of data erasure software for the enterprise market, Blancco is well positioned to exploit the growing requirement for...


15 Mar, 2017, 09:17 ET Edison Issues Initiation on Polypipe (PLP)

We expect forthcoming FY16 results (30 March) to highlight the strength of Polypipe's model with a strong y-o-y uplift in earnings and good cash...


08 Mar, 2017, 04:42 ET Edison Issues ADR Update on Thin Film Electronics (TFECY)

For Thinfilm (THIN), 2016 has been principally dominated by a steadily growing list of new client partnerships, preparations for the move to the...


28 Feb, 2017, 11:10 ET Edison Issues ADR Update on Hutchison China MediTech (HCM)

Hutchison (HCM) and partner AstraZeneca presented positive preliminary data from the ongoing phase II proof-of-concept trial evaluating...


28 Feb, 2017, 09:12 ET Edison Issues Outlook on TxCell (TXCL)

TxCell's novel CAR-modified regulatory T-cell (CAR Treg) platform is developing well. CAR Tregs offer a powerful and versatile new approach to...


16 Feb, 2017, 10:36 ET Edison Issues ADR Outlook on Prima BioMed (PBMD)

Prima BioMed maintains its leadership in LAG-3 immunotherapies with the initiation of the randomized Phase IIb component of the AIPAC trial of...